William White

William White

William White joined InvestorPlace.com in 2013. He writes about a wide range of stocks across all industries, especially so-called “meme stocks” or “Reddit stocks.” Recently, his area of expertise has expanded to include cryptocurrencies, such as Bitcoin, Dogecoin, Ripple, and a myriad of other altcoins. Traders looking for additional insight into the stock market can follow him on Twitter.

Recent Articles

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

It's time to start off the final trading day of the week with a breakdown of the biggest pre-market stock movers for Friday morning!

Student Loan Forgiveness Updates: Check Your Email as Biden Doubles Down

President Joe Biden's Administration continues to push forward with student loan forgiveness as it starts sending emails to borrowers.

Boar’s Head Recalls 2024: 7 Million Pounds of Deli Meat, Poultry Pulled

The Boar’s Head recalls is expanding with the company adding another 7 million pounds of deli meat and poultry to its previous recall.

Spirit Airlines Changes: Get Ready for Higher Fares, More In-Flight Perks

Spirit Airlines is changing up its pricing options to offer more perks to customers who choose to pay more for their seats.

Ground Cinnamon Recalls: What to Know as FDA Issues Alert Over Lead Levels

New ground cinnamon recalls are in effect as the FDA warns consumers about increased lead levels in some of these products.

Why Are Chip Stocks Up Today?

Chip stocks are up today and investors wondering why will find all of the news explaining the rally in the sector on Wednesday.

FibroGen Layoffs 2024: What to Know About the Latest FGEN Job Cuts

FibroGen layoffs are in the news Wednesday after the biopharmaceutical company announced plans to cut jobs after failed clinical trials.

Match Group Layoffs 2024: What to Know About the Latest MTCH Job Cuts

Match Group layoffs are a hot topic on Wednesday as the dating website operator is preparing to reduce its headcount due to demand changes.

Why is Macrogenics (MGNX) Stock Down 28% Today?

Macrogenics stock is down on Wednesday after MGNX investors learned that the company is discontinuing a Phase 2 clinical trial.

Why Is FibroGen (FGEN) Stock Down 44% Today?

FibroGen stock is down on Wednesday as FGEN investors react to the company's failed clinical trials for its pancreatic cancer treatment.